{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:17:55Z","timestamp":1753888675053,"version":"3.41.2"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT To assess SARS-CoV-2 reinfection incidence in the post-vaccination period, we carried out a prospective cohort study of blood donors from Amazonas and Sao Paulo States, Brazil. Anti-nucleocapsid immunoglobulin (IgG anti-N) tests carried out by blood centers in 2020 were used to identify previous SARS-CoV-2 infections in blood donors and divide them into two groups: prior infection (n=386) and no prior infection (n=111). From March 2021 to January 2022, donors were followed up for six months, during which IgG anti-N and real-time reverse transcription polymerase chain reaction tests were performed every two months to detect SARS-CoV-2 infections. Symptoms and vaccination status were also recorded. Most participants (93.6%) received at least one COVID-19 vaccine dose. Reinfection incidence in the prior infection group equaled 1.39 per 100 person-months (95% CI: 0.90\u20132.06), in comparison to 2.68 per 100 person-months (95% CI: 1.28\u20134.93) for new infections in those without prior infection. The incidence risk ratio showed no significant association (0.52, 95% CI: 0.25\u20131.13). However, prior infection significantly increased the probability of remaining uninfected (Log-rank: p=0.009). Most reinfections (84%) showed no symptoms and occurred post-vaccination during the Delta and Omicron waves. IgG anti-N seroprevalence decreased in the prior infection group (from 35.5% at baseline to 22.5% after six months, p=0.003). Despite no significant incidence risk ratio differences, donors with prior infection had lower infection rates and a higher likelihood of remaining uninfected. Persistent post-vaccination asymptomatic infections emphasize the need for ongoing prevention, genomic surveillance, and booster programs to address emerging variants and protect vulnerable populations.<\/jats:p>","DOI":"10.1590\/s1678-9946202567033","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:39:51Z","timestamp":1748259591000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence of SARS-CoV-2 reinfection among blood donors from two Brazilian states in the post-vaccination period: a prospective cohort study"],"prefix":"10.1590","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-2693","authenticated-orcid":false,"given":"Monike Aparecida Matos de","family":"Oliveira","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiane Sena de","family":"Castro","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Amazonas,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Buccheri","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute,  United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-3118","authenticated-orcid":false,"given":"Tassila","family":"Salomon","sequence":"additional","affiliation":[{"name":"Faculdade Ci\u00eancias M\u00e9dicas de Minas Gerais,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Luana","family":"Dinardo","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Pr\u00f3-Sangue Hemocentro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Cristina Gomes","family":"Moura","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myuki Alfaia Esashika","family":"Crispim","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar de Hematologia e Hemoterapia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson Abrahim","family":"Fraiji","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Hospitalar de Hematologia e Hemoterapia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2623-5126","authenticated-orcid":false,"given":"Ester Cerdeira","family":"Sabino","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade Municipal de S\u00e3o Caetano do Sul,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-2275","authenticated-orcid":false,"given":"Cec\u00edlia Salete","family":"Alencar","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"series-title":"WHO COVID-19 dashboard","key":"ref1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria NR","year":"2021","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12879-022-07094-y","article-title":"Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil","volume":"22","author":"Prete Jr CA","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1590\/0103-1104202113114i","article-title":"Health collapse in Manaus: the burden of not adhering to non-pharmacological measures to reduce the transmission of Covid-19","volume":"45","author":"Barreto IC","year":"2021","journal-title":"Saude Debate"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet T","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall V","year":"2022","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e4223","DOI":"10.1093\/cid\/ciaa1866","article-title":"Reinfection with SARS-CoV-2: implications for vaccines","volume":"73","author":"Cohen JI","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/cid\/ciab014","article-title":"Confirmed reinfection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) variant VOC-202012\/01","volume":"73","author":"Harrington D","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"111299","DOI":"10.1016\/j.jtbi.2022.111299","article-title":"Patterns of reported infection and reinfection of SARS-CoV-2 in England","volume":"556","author":"Keeling MJ","year":"2023","journal-title":"J Theor Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa","volume":"376","author":"Pulliam JR","year":"2022","journal-title":"Science"},{"key":"ref11","article-title":"Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China","volume":"95","author":"Yu W","year":"2023","journal-title":"J Med Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijid.2022.07.075","article-title":"Epidemiological assessment of SARS-CoV-2 reinfection","volume":"123","author":"Almadhi M","year":"2022","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1007\/s42770-024-01467-y","article-title":"SARS-CoV-2 reinfection rate before and after VOC Omicron emergence: a retrospective study in Brazil","volume":"55","author":"Fonseca PL","year":"2024","journal-title":"Braz J Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23917","article-title":"Effectiveness associated with vaccination after COVID-19 recovery in preventing reinfection","volume":"5","author":"Lewis N","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","article-title":"Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence","volume":"397","author":"Sabino EC","year":"2021","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.5642","article-title":"COVID-19: immunopathology, pathophysiological mechanisms, and treatment options","volume":"254","author":"van Eijk LE","year":"2021","journal-title":"J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"100108","DOI":"10.1016\/j.gloepi.2023.100108","article-title":"The changing profile of SARS-CoV-2 serology in Irish blood donors","volume":"5","author":"Coyne D","year":"2023","journal-title":"Glob Epidemiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(21)00675-9","article-title":"SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)","volume":"397","author":"Hall VJ","year":"2021","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study","volume":"397","author":"Hansen CH","year":"2021","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"20763","DOI":"10.1038\/s41598-022-24220-7","article-title":"Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis","volume":"12","author":"Deng L","year":"2022","journal-title":"Sci Rep"},{"journal-title":"Dashboard genomic network","key":"ref21","article-title":"Minist\u00e9rio da Sa\u00fade. Funda\u00e7\u00e3o Oswaldo Cruz"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1002\/jmv.28026","article-title":"Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study","volume":"94","author":"Jang EJ","year":"2022","journal-title":"J Med Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/v15040967","article-title":"SARS-CoV-2 reinfection and severity of the disease: a systematic review and meta-analysis","volume":"15","author":"Nguyen NN","year":"2023","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41598-022-25908-6","article-title":"Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic","volume":"13","author":"Guedes AR","year":"2023","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ijid.2022.07.025","article-title":"SARS-CoV-2 reinfection rate and outcomes in Saudi Arabia: a national retrospective study","volume":"122","author":"Al-Otaiby M","year":"2022","journal-title":"Int J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"eabn8057","DOI":"10.1126\/scitranslmed.abn8057","article-title":"Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection","volume":"14","author":"Evans JP","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/v15071551","article-title":"SARS-CoV-2 reinfections in health-care workers, 1 March 2020-31 January 2023","volume":"15","author":"Cegolon L","year":"2023","journal-title":"Viruses"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162007","article-title":"SARS-CoV-2 reinfections during the Delta and Omicron waves","volume":"7","author":"Morris CP","year":"2022","journal-title":"JCI Insight"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.3390\/ijerph20043335","article-title":"Severity and outcomes of SARS-CoV-2 reinfection compared with primary infection: a systematic review and meta-analysis","volume":"20","author":"Deng J","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","article-title":"SARS-CoV-2 hybrid immunity: the best of both worlds","volume":"228","author":"Lasrado N","year":"2023","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu J","year":"2022","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton R","year":"2022","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1588.e14","DOI":"10.1016\/j.cell.2022.03.018","article-title":"Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity","volume":"185","author":"Rodda LB","year":"2022","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2169\/internalmedicine.9628-22","article-title":"The proportion of long-term response to anti-N IgG antibody after 12 months for COVID-19 subclinical infections and a longitudinal survey for COVID-19 subclinical infections in 2021","volume":"61","author":"Matsuba I","year":"2022","journal-title":"Intern Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/eji.202149535","article-title":"Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans","volume":"51","author":"Haveri A","year":"2021","journal-title":"Eur J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"23216","DOI":"10.1038\/s41598-021-02659-4","article-title":"Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients","volume":"11","author":"Chansaenroj J","year":"2021","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-7568(21)00282-8","article-title":"Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England","volume":"3","author":"Krutikov M","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1093\/cid\/ciab004","article-title":"The duration, dynamics, and determinants of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers","volume":"73","author":"Lumley SF","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijid.2021.09.060","article-title":"Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection","volume":"113","author":"Azak E","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12250-020-00329-9","article-title":"Viral and antibody kinetics of COVID-19 patients with different disease severities in acute and convalescent phases: a 6-month follow-up study","volume":"35","author":"Zhang X","year":"2020","journal-title":"Virol Sin"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652025000100214&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:39:57Z","timestamp":1748259597000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652025000100214&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"alternative-id":["S0036-46652025000100214"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202567033","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e33"}}